Skip to main content
メニュー
Revvity logo
Contact us
JP
Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

australia.webp Australia
austria.webp Austria
belgium.webp Belgium
brazil.webp Brazil *
canada.webp Canada
china.webp China *
denmark.webp Denmark
finland.webp Finland
france.webp France
germany.webp Germany
hong-kong.webp Hong Kong (China) *
india.webp India *
ireland.webp Ireland
italy.webp Italy
japan.webp Japan *
luxembourg.webp Luxembourg
mexico.webp Mexico *
netherlands.webp Netherlands
norway.webp Norway
philippines.webp Philippines *
republic of korea.webp Republic of Korea *
singapore.webp Singapore *
spain.webp Spain
sweden.webp Sweden
switzerland.webp Switzerland
thailand.webp Thailand *
uk.webp United Kingdom
usa.webp United States
Breadcrumb
...
  • ホーム
  • Resources
  • Blog

Revvityブログ

発見から治療までのイノベーションを促進

Latest

From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.

Cell and Gene Therapy December 8, 2025 - 5 min read
Read
Drug Development

4 high-content imaging myths every researcher should know.

November 17, 2025 - 1 min read
Read
Drug Development

Oligonucleotide drug discovery: its journey through time.

November 5, 2025 - 4 min read
Read
Drug Development, Disease Research

The significance of longitudinal in vivo imaging in advancing drug discovery.

November 7, 2024 - 3 min read
Read
Physiological Model Solutions, Drug Development

Revolutionizing drug safety: tools reshaping toxicology.

August 6, 2024 - 4 min read
Read
Drug Development

Antibody detection provides insights into long-term viral immunity and the efficacy of vaccines.

July 11, 2024 - 3 min read
Read
Physiological Model Solutions, Drug Development

Revolutionizing predictive toxicology testing with organ-on-chip models.

June 19, 2024 - 2 min read
Read
Drug Development

Drug repurposing for antiviral therapies: research and strategies with high throughput screening.

May 29, 2024 - 2 min read
Read
Drug Development

Radiometric detection for precise and efficient molecular quantitation.

May 6, 2024 - 1 min read
Read
Drug Development

Improving drug safety through cardiotoxicity assessment.

April 29, 2024 - 2 min read
Read
Drug Development

How to streamline your mAb hybridoma screening.

April 4, 2024 - 2 min read
Read
Pagination
  • Current page 1
  • ページ 2
  • Next page Next
  • Last page 最後 »
line

ご質問がございましたら、
お気軽にお問い合わせください。

お問合せ
Revvity Logo

©2025 Revvity - All rights reserved

Revvity is a trademark of Revvity, Inc. All other trademarks are the property of their respective owners.